What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Learn how a yield-focused dividend ETF can fit into a retirement plan, delivering income while maintaining simplicity and liquidity.
19,425 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Crypto hedge funds started 2026 with losses as volatility rose, prompting a shift to market-neutral and relative-valu...
Bitcoin has entered a stark profit-and-loss juncture, with a growing share of the supply losing money as prices hover...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
NVDL surged 5.5% on Monday as chip stocks rebounded and NVIDIA led a broader semiconductor rally. The move comes as i...
A January 12, 2026 bill aims to ban lawmakers and families from buying stocks, with public notice and hefty penalties...
In 2026, Interactive Brokers rolled out a major update with lower costs, broader market access, and AI-driven researc...
When the market rallies but your upside seems limited, it helps to look for growth stocks down right now. This articl...
A U.S.-listed ETF now prioritizes balance-sheet quality in developed markets, offering overseas exposure without weak...
When a major holder severs a stake in a big airline, it signals shifts in sentiment. We break down what cobalt capita...
Bitcoin breached a critical price point, fueling renewed selling across crypto markets. Analysts warn that further de...
The EUAD ETF has rebounded, prompting investors to focus on three defense stocks to watch as European budgets firm up...